Choice of Treatment Regimen as Add-On to Insulin in Japanese Patients with Type 2 Diabetes Mellitus: Physicians' Perspective in a Real-World Setting, Insight from a Web Survey.

导出 OA

翻译打印收藏纠错

第一作者： Kota,Imai

第一单位： Medical Division, Novartis Pharma K.K., Tokyo, Japan.

作者： Kota,Imai ^[1] ; Hiroki,Murayama ^[2] ; Takahisa,Hirose ^[3]

作者单位： Medical Division, Novartis Pharma K.K., Tokyo, Japan. ^[1] Medical Division, Novartis Pharma K.K., Tokyo, Japan. hiroki.murayama@novartis.com. ^[2] Division of Diabetes, Metabolism and Endocrinology, Department of Medicine, School of Medicine, Toho University, Tokyo, Japan. ^[3]

关键词 Diabetologists Dipeptidyl peptidase-4 inhibitor General physicians Insulin Japanese patients Metformin Questionnaire Type 2 diabetes mellitus Web-based survey

DOI 10.1007/s13300-018-0476-3

PMID 30058059

发布时间 2023-05-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交